| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0003 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.0007 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.0009 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.001 |